Limbago, Brandi

Burden of Clostridium difficile Infection in the United States

Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine

Clostridium difficile and Clostridium perfringens researchInfection Control in Healthcare

Cited by 2,641

Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014.

Weiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R., & Sievert, D. M. (2016) · Infection Control & Hospital Epidemiology

Antibiotic Resistance in BacteriaAntibiotic Use and Resistance

Cited by 1,313

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J. (2011) · Clinical Infectious Diseases

Antibiotic Resistance in BacteriaAntibiotic Use and Resistance

Cited by 1,033

Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008

Talan, D. A., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., Limbago, B., Albrecht, V., Moran, G. J., & for The EMERGEncy ID Net Study Group (2011) · Clinical Infectious Diseases

Antimicrobial Resistance in StaphylococcusStreptococcal Infections and Treatments

Cited by 300

Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020–May 2021

Paul, P., France, A. M., Aoki, Y., Batra, D., Biggerstaff, M., Dugan, V., Galloway, S., Hall, A. J., Johansson, M. A., Kondor, R. J., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 92